Active	Status	Sponsor type	Region	Phase	Filter
5 Active 0 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « June » « 2025 » M T W T F S S 26 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4 5 6   - « June » « 2025 » M T W T F S S 26 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4 5 6   Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Varga, Ágnes
RESPONSE, NCT05743608: NEXThaleR Real-world Study Assessing the EffectivenesS of BDP/FF/G Fixed triPle cOmbiNation on Symptom scorEs in COPD Patients	Completed	N/A	1336	Europe		Chiesi Hungary Ltd., Chiesi Slovenija, d.o.o., Chiesi Bulgaria, CHIESI CZ s.r.o.	COPD	10/24	05/25
STRENGTH, NCT06678191: Investigation of Fixed Triple Inhaled Combination in Asthmatic Patients, in a Real-life Setting	Recruiting	N/A	800	Europe	BDP/FF/G (Beclomethasone diprprionate, formoterol fumarate, glycopyrronium bromide) 172/5/9 μg	Chiesi Hungary Ltd.	Asthma, Chronic Obstructive Pulmonary Disease (COPD), Asthma Bronchiale	10/26	08/27
Steinleir, Mária
RESPONSE, NCT05743608: NEXThaleR Real-world Study Assessing the EffectivenesS of BDP/FF/G Fixed triPle cOmbiNation on Symptom scorEs in COPD Patients	Completed	N/A	1336	Europe		Chiesi Hungary Ltd., Chiesi Slovenija, d.o.o., Chiesi Bulgaria, CHIESI CZ s.r.o.	COPD	10/24	05/25
Beke, Márta
RESPONSE, NCT05743608: NEXThaleR Real-world Study Assessing the EffectivenesS of BDP/FF/G Fixed triPle cOmbiNation on Symptom scorEs in COPD Patients	Completed	N/A	1336	Europe		Chiesi Hungary Ltd., Chiesi Slovenija, d.o.o., Chiesi Bulgaria, CHIESI CZ s.r.o.	COPD	10/24	05/25
STRENGTH, NCT06678191: Investigation of Fixed Triple Inhaled Combination in Asthmatic Patients, in a Real-life Setting	Recruiting	N/A	800	Europe	BDP/FF/G (Beclomethasone diprprionate, formoterol fumarate, glycopyrronium bromide) 172/5/9 μg	Chiesi Hungary Ltd.	Asthma, Chronic Obstructive Pulmonary Disease (COPD), Asthma Bronchiale	10/26	08/27

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Varga, Ágnes
RESPONSE, NCT05743608: NEXThaleR Real-world Study Assessing the EffectivenesS of BDP/FF/G Fixed triPle cOmbiNation on Symptom scorEs in COPD Patients	Completed	N/A	1336	Europe		Chiesi Hungary Ltd., Chiesi Slovenija, d.o.o., Chiesi Bulgaria, CHIESI CZ s.r.o.	COPD	10/24	05/25
STRENGTH, NCT06678191: Investigation of Fixed Triple Inhaled Combination in Asthmatic Patients, in a Real-life Setting	Recruiting	N/A	800	Europe	BDP/FF/G (Beclomethasone diprprionate, formoterol fumarate, glycopyrronium bromide) 172/5/9 μg	Chiesi Hungary Ltd.	Asthma, Chronic Obstructive Pulmonary Disease (COPD), Asthma Bronchiale	10/26	08/27
Steinleir, Mária
RESPONSE, NCT05743608: NEXThaleR Real-world Study Assessing the EffectivenesS of BDP/FF/G Fixed triPle cOmbiNation on Symptom scorEs in COPD Patients	Completed	N/A	1336	Europe		Chiesi Hungary Ltd., Chiesi Slovenija, d.o.o., Chiesi Bulgaria, CHIESI CZ s.r.o.	COPD	10/24	05/25
Beke, Márta
RESPONSE, NCT05743608: NEXThaleR Real-world Study Assessing the EffectivenesS of BDP/FF/G Fixed triPle cOmbiNation on Symptom scorEs in COPD Patients	Completed	N/A	1336	Europe		Chiesi Hungary Ltd., Chiesi Slovenija, d.o.o., Chiesi Bulgaria, CHIESI CZ s.r.o.	COPD	10/24	05/25
STRENGTH, NCT06678191: Investigation of Fixed Triple Inhaled Combination in Asthmatic Patients, in a Real-life Setting	Recruiting	N/A	800	Europe	BDP/FF/G (Beclomethasone diprprionate, formoterol fumarate, glycopyrronium bromide) 172/5/9 μg	Chiesi Hungary Ltd.	Asthma, Chronic Obstructive Pulmonary Disease (COPD), Asthma Bronchiale	10/26	08/27